Results 31 to 40 of about 3,391 (207)
Ginkgo biloba extract and long-term cognitive decline: a 20-year follow-up population-based study.
PLoS ONE, 2013 BackgroundNumerous studies have looked at the potential benefits of various nootropic drugs such as Ginkgo biloba extract (EGb761®; Tanakan®) and piracetam (Nootropyl®) on age-related cognitive decline often leading to inconclusive results due to small ...
Hélène Amieva +4 more
doaj +1 more source
Effects of parenteral papaverine and piracetam administration on cochlea following acoustic trauma
Noise and Health, 2018 Introduction: Noise exposure, the main cause of hearing loss in countries with lot of industries, may result both in temporary or permanent hearing loss.
Nurcan Yurtsever Kum +5 more
doaj +1 more source
Single-dose piracetam effects on global complexity measures of human spontaneous multichannel EEG
, 1999 Global complexity of 47-channel resting electroencephalogram (EEG) of healthy young volunteers was studied after intake of a single dose of a nootropic drug (piracetam, Nootropil® UCB Pharma) in 12 healthy volunteers. Four treatment levels were used: 2.4,
Christoph M. Michel +13 more
core +1 more source
Synthesis and Action of N-acylphenylacetamides and N-acyl-β-ketoamides on the Central Nervous System
Разработка и регистрация лекарственных средств, 2022 Introduction. One of the most promising directions in the search for biologically active compounds is the molecular design of biologically active compounds containing a known pharmacoform fragment.
I. P. Kodonidi +2 more
doaj +1 more source
Neurobehavioral Impacts of Xylazine and Piracetam Interaction on NADH Oxidase in the Rat Brain
Kufa Journal for Veterinary Medical SciencesIn the present study, the effects of different doses of xylazine combined with piracetam were investigated through different behavioral experiments. Xylazine is alpha 2 adrenergic agonist a veterinary sedative, and analgesic agent.
Shaker M. Kermasha +1 more
doaj +1 more source
Movement Disorders Associated with 22q11.2 Microdeletion: A Scoping Review
Movement Disorders Clinical Practice, EarlyView.Abstract Background Movement disorders have recently emerged as important neurologic manifestations of the 22q11.2 microdeletion that affects nearly one in every 2000 live births. Objective We aimed to map the existing evidence regarding the spectrum, diagnosis and treatment, and etiopathogenesis of movement disorders associated with 22q11.2 ...
Nikolai Gil D. Reyes +6 more
wiley +1 more source
Agranulocitose em pacientes com epilepsia mioclônica progressiva fazendo uso de piracetam: relato de um caso. [PDF]
, 1992 Trabalho de Conclusão de Curso - Universidade Federal de Santa Catarina, Centro de Ciências da Saúde, Departamento de Clínica Médica, Curso de Medicina, Florianópolis ...
Carneiro, Álvaro Rogério Novaes
core
Acta Ophthalmologica, EarlyView.Abstract Purpose To identify associations between systemic drugs and cataract surgery in Finland. Methods A historic cohort study based on administrative data. Endpoint event was cataract surgery. Use of drugs in question was based on redeemed prescriptions and consisted of 156 drugs.
Antti Riikonen +3 more
wiley +1 more source
Pharmaceuticals, 2022 Cancer chemotherapy is known to cause cognitive defects in patients. Our study investigated the effect of piracetam (PIRA; 200 or 400 mg/kg) against doxorubicin (DOX)-induced cognitive deficits in a rat model. The cognitive parameters were analyzed using
Vasudevan Mani +4 more
doaj +1 more source
Benign by design: A paradigm shift in cosmetic ingredient development
International Journal of Cosmetic Science, EarlyView.Benign by design strategies enable the creation of biodegradable cosmetic ingredients, reducing environmental persistence while maintaining the intended biological activity. This work compiles design rules and tools to guide the development of more sustainable molecules for the cosmetics industry.
Sandra Mota +3 more
wiley +1 more source